Back

Comparative effectiveness of propafenone and aksaritmin for conversion of paroxysmal atrial fibrillation

4 April 2022 (08:30 - 20:10)
Organised by:
Congress Presentation Part of: ePosters Day 2 Antiarrhythmic Drug Treatment EHRA Premium Access EHRA 2022

About the speaker

Photo
Assistant Professor Husniddin Kuchkarov

Alfraganus University, Tashkent (Uzbekistan)

131 More presentations in this session

Presentation thumbnail
Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion
Doctor L. Sgarra (Acquaviva Delle Fonti, IT)
Abstract Slides
Presentation thumbnail
Pure and impure tachycardiomiopathy: key differences and long term prognosis
Doctor G. Stronati (Ancona, IT)
Abstract Slides
Presentation thumbnail
Prognostic value of plasma neutrophil gelatinase-associated lipocalin for cardiovascular events in patients with chronic heart failure and atrial fibrillation
Professor D. Lashkul (Zaporizhzhya, UA)
Abstract Slides
Presentation thumbnail
Interatrial block as a prognosticator of new-onset atrial fibrillation: prospective observational study of 8012 adults
Mr E. Abdovic (Zenica, BA)
Abstract Slides
Presentation thumbnail
CHA2DS2-VASc score and the risk of death in atrial fibrillation
Doctor A. Aro (Helsinki, FI)
Abstract Slides

Access the full session

Session thumbnail
ePosters Day 2

The Event

Event poster

EHRA 2022

4 April 2022 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources